Aug 2026· Neurobiology of Disease· Vol 229, pp.
107592
· 0 citations· 67 references
Medicine
TL;DR
A novel PINK1-(phospho)p47-STIP1 signaling axis that promotes dendritic complexity and protects against tau-induced neurodegeneration in cortical neurons is highlighted.
Abstract
Microtubule associated protein tau (tau) contributes to the pathogenesis of AD and some forms of Frontotemporal Lobar Dementia wherein dendritic simplification is strongly related to cognitive dysfunction. Loss of function mutations in PTEN-induced kinase 1 (PINK1) cause recessive early-onset Parkinson's disease with dementia, and reduced wild-type PINK1 expression is observed in Alzheimer's disease (AD). We previously found that PINK1 interacts with valosin-containing protein (VCP) and promotes phosphorylation of the VCP co-factor NSFL1C (p47). This study was designed to test the hypothesis that PINK1 rescues tau-induced dendritic simplification through the VCP-p47 pathway, and to define neuroprotective mechanisms downstream of p47 phosphorylation. Mouse primary cortical neurons were transfected with 2N4R-Tau and plasmids encoding components of the PINK1-VCP-p47 signaling pathway and the impact on Tau-mediated dendritic injury was assessed. Immunoprecipitation-mass spectrometry, immunoblotting, RNAi and Sholl analysis were performed to define downstream mechanisms of neuroprotection. Tau-induced dendritic shortening and simplification was fully rescued by co-expression of PINK1, VCP, p47 or the p47-S176D phosphomimic (p47D), but not by the non-phosphorylatable p47-S176A (p47A) variant. Pathway analysis showed enhanced interactions of p47D with proteins in the Rho-GTPase pathway. Immunoprecipitation confirmed that STIP1 interacts with p47D to a significantly higher degree than p47A. Overexpression of STIP1 rescued tau-mediated dendritic simplification. Moreover, STIP1 siRNA impaired the neuroprotective effects of both PINK1 and p47D, indicating an essential role in the PINK1-p47D neuroprotection pathway. The current study highlights a novel PINK1-(phospho)p47-STIP1 signaling axis that promotes dendritic complexity and protects against tau-induced neurodegeneration in cortical neurons.
Circ_0004801 acts as an upstream regulator of TTBK1 by sequestering miR-7688-5p, thereby promoting tau hyperphosphorylation and cognitive impairment in AD and may represent a potential target for tau-directed intervention.
Qing-Qing Li, Jie Xiao, Guo-Rong Deng et al.· Journal of Alzheimer's Disea...· 0 citations
Familial Alzheimer’s disease (FAD) is an accelerated form of dementia affecting cholinergic neurons. Despite several efforts, no single drug or treatment has demonstrated complete efficacy. Therefore, finding effective therapeutic agents is imperative. Previous studies have shown that the PSEN1 I416T variant induces FA...
N. Gomez-Sequeda, M. Jimenez-Del-Rio, C. Velez-Pardo· Kinases and Phosphatases· 0 citations
Intracellular neurofibrillary tangles formed from hyperphosphorylated tau and extracellular amyloid plaques containing aggregated Aβ-peptides, specific cleavage products of the Amyloid Precursor Protein (APP), are the primary histopathological hallmarks of Alzheimer’s Disease (AD), the leading cause of dementia in huma...
Bhavna Verma, A. Cording, Lewis Blincowe et al.· bioRxiv· 0 citations
GDE2 is identified as a component of the complex regulatory network that controls Tau phosphorylation in the context of tauopathy and provides insight into putative pathways relevant to Tau pathologies observed in disease.
Consuelo Jimenez-Ornelas, S. Sockanathan· bioRxiv· 0 citations
Investigating the mechanisms underlying the reduction of p-tau217+ EVs to uncover AD therapeutic targets reveals a role of HSPA8 in regulating the MVB-mediated EV release and tau propagation, and highlights HSPA8 as a promising therapeutic target for modifying AD progression.
Bin Xu, Zhen Guo, Jun Chen et al.· Translational Neurodegenerat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.